Statement Of Cash Flows [Abstract]

GENFLOW BIOSCIENCES PLC - Filing #5893549

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)	1,587,235 GBP	- GBP	- GBP	—	- GBP	1,587,235 GBP	- GBP	1,860,345 GBP	—	- GBP	1,860,345 GBP	- GBP	—
Adjustments to reconcile profit (loss) [abstract]
Adjustments for depreciation and amortisation expense	1,179 GBP	—	—	—	—	—	—	1,034 GBP	—	—	—	—	—
Adjustments for share-based payments	- GBP	—	—	—	—	—	—	- GBP	—	—	—	—	—
Cash flows from (used in) operating activities	1,082,273 GBP	—	—	—	—	—	—	1,660,875 GBP	—	—	—	—	—
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities	- GBP	—	—	—	—	—	—	2,439 GBP	—	—	—	—	—
Cash flows from (used in) investing activities	- GBP	—	—	—	—	—	—	2,439 GBP	—	—	—	—	—
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities	656,635 GBP	—	—	—	—	—	—	- GBP	—	—	—	—	—
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes	425,638 GBP	—	—	—	—	—	—	1,663,314 GBP	—	—	—	—	—
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents	20,346 GBP	—	—	—	—	—	—	8,937 GBP	—	—	—	—	—
Cash and cash equivalents	—	—	—	278,682 GBP	—	—	—	—	683,974 GBP	—	—	—	2,356,225 GBP